BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會

PROGRAM

2023 Focus Symposia

​​

7/27

Protecting your Life Sciences Innovations:Challenges in the USA and Europe

Obtaining global protection for your innovation can be challenging, particularly when considering the different rules and legal systems in the USA and Europe. In this seminar we will explain the post-grant challenges to patents that can be launched in the USA and in Europe, highlighting the opportunities and potential pitfalls within the two legal systems. We will also discuss the Biologics Price Competition and Innovation Act (BPCIA) in the USA and the litigation that has followed. Finally, we will have a panel discussion on the impact of clinical trials on patentability of inventions, addressing the relevance of publication of clinical trial data to assessment of novelty and inventive step in both the USA and in Europe.

Date / Time: July 27 13:30-17:00 | Registration starts from 13:00

Venue:Room 504A, Nangang International Exhibition Center, Hall1 (TaiNEX 1) / No.1, Jingmao 2nd Rd., Nangang District, Taipei City (南港展覽館一館,5樓504A會議室)

Co-organizer: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Registration Link:https://forms.gle/mB3zEc32RYBT7oQy8

Agenda

Time Activities
13:00-13:30 Registration
13:30-13:45 Opening Remarks | Introduction of Finnegan and the speakers
Ming-Tao Yang, Partner, Finnegan
13:45-14:45 Navigating your Life Sciences Post-Grant Challenges: Tips for best practice when you are challenging or being challenged in the EPO or USPTO
14:45-15:45 The Biologics Price Competition and Innovation Act (BPCIA) and the Changing Landscape for Biologics and Biosimilars
15:45-16:00 Break
16:00-17:00 Panel Discussion:The Impact of Clinical Trials on Patentability—novelty, non-obviousness, and inherency
Moderator: Professor Su-Hua Lee, Ph.D. College of Law, NTU
17:00 End

Speaker's Bio

Amanda K. Murphy
Maeve O'Flynn

Yieyie Yang

Contact:

Laila Liu
Tel: (02)2783-6028ext.25
Email: bioasiataiwan@gmail.com

7/27

Pushing Frontiers in Drug Screening: Innovation in Human iPSC Technology, 3D Culture Models, and High-Throughput Screening for Accelerated Drug Discovery

Due to the high demand for innovations in drug screening, LumiSTAR Biotechnology (Taiwan), HCS Pharma (France), and Molecular Device (USA) co-organized a symposium at BIO Asia-Taiwan 2023 this year, focusing on cutting-edge technologies for high-throughput phenotypic screening.

This session will showcase the revolutionary potential of Human iPSC (induced pluripotent stem cell) technology, advanced 3D culture models, and high-content/high-throughput screening techniques along with state-of-the-art imaging analysis technologies.

Attendees will gain insights into how these advancements are driving accelerated drug discovery. Join us to engage with leading experts and stay at the forefront of the rapidly evolving field of drug screening.

Date / Time: July 27 13:30-17:00

Venue:Room 403, Nangang International Exhibition Center, Hall1 (TaiNEX 1) / No.1, Jingmao 2nd Rd., Nangang District, Taipei City (南港展覽館一館4樓403會議室)

Organizer: LumiSTAR Biotechnology, HCS Pharma, Molecular Devices

Registration Link: https://www.accupass.com/go/drug_screening

Agenda

Time Event/Presentation

13:30-14:00

Registration

14:00-14:10

Opening Remarks & Group Photo

14:10-14:50

Transforming Drug Discovery: Leverage the Power of LumiRDT™ with Advanced Human iPSC Technology and High-throughput Screening

Yu-Fen Chang, CEO, LumiSTAR Biotechnology (Taiwan)

14:50-15:30

BIOMIMESYS® Hydroscaffold, a Ready-to-use Organ-specific Extracellular Matrix for Relevant Phenotypic Screening

Nathalie MaubonCEO/CSO, HCS Pharma (France)

15:30-16:10

Overcoming the Barriers to 3D Organoid Adoption: A Complete Workflow to Enable Large-scale Production of Organoids and their Use in Automated High-throughput Applications

Angeline Lim, Senior Applications Scientist, Molecular Devices (USA)

16:10-16:15

Closing Remarks

16:15-17:00

Refreshment & Networking

7/28

Digital Health: Data Use & Cybersecurity

In this symposium, Baker McKenzie will discuss the focus and trend on digitalization and data and its impact in the healthcare industry, the challenges when healthcare industry incorporates data privacy into compliance programs, and the views about the best practice.  Baker McKenzie will also introduce the key legal and regulatory issues, from the ideation stage to market, that innovators of AI/ML products should consider, as well as the latest cybersecurity trends internationally and share the experiences in Baker McKenzie's leading cases in healthcare sector with key takeaways.

Date / Time: July 28 9:00-12:00/ On-demand

Venue:Room 505A, Nangang International Exhibition Center, Hall1 (TaiNEX 1) / No.1, Jingmao 2nd Rd., Nangang District, Taipei City (南港展覽館一館5樓505A會議室)/ Online event platform

Co-organizer: Baker McKenzie, Taipei (國際通商法律事務所)

Registration Link:https://forms.gle/LhvG88fvxoEdfFGc9

Agenda

Duration Topic / Speaker
9:00-9:30

Registration

9:30-9:40

Opening Remarks

Session Chair: Michael Wong, Taipei & Prior Chair of Asia Pacific, Baker McKenzie (國際通商法律事務所 汪士邁特聘資深顧問)

9:40-10:00

Topic 1: Healthcare 4.0 the Way to Realize Future Care

Speaker: Dr. Peter Wu, CEO, ASUS Cloud Corporation (華碩雲端股份有限公司 吳漢章總經理)

10:00-10:20

Topic 2: Data and Digital Health

Speaker: Jo-Fan Yu, Partner and Head of Digital Transformation, Baker McKenzie, Taipei (國際通商法律事務所 余若凡律師)

10:20-10:40

Topic 3: Development and Launch of AI/ML Products

Speaker: Belle Chiou, Partner and Head of Healthcare & Life Sciences, Baker McKenzie, Taipei (國際通商法律事務所 邱子綾律師)

10:40-11:00

Topic 4: Cybersecurity in Healthcare Sector

Speakers: Anna Hwang, Executive Partner and Chair of Dispute Resolution, Baker McKenzie, Taipei (國際通商法律事務所 黃麗蓉律師) & Cyrus Vance Jr., Partner, Baker McKenzie, New York & Global Chair of Cybersecurity, Baker McKenzie

11:00-11:10

Break & Photo

11:10-11:50

Panel Discussion & Interactive Q&A

Moderator:
Belle Chiou, Partner and Head of Healthcare & Life Sciences, Baker McKenzie, Taipei (國際通商法律事務所 邱子綾律師)

Panelists:

11:50-12:00

Social Networking

Contact:

Laila Liu
Tel: (02)2783-6028ext.25
Email: bioasiataiwan@gmail.com

7/28

TCI Event

TBD

7/29

TMU x BE x SCHS Demoday

TMU x BE x SCHS Demoday: The Next HealthTech Frontier Transforming Hospitals

活動資訊

TMU x BE x SCHS Demoday 即將於台北時間 2023年 7月 29 日星期六上午12時舉辦 Demo Day
實體活動地點:台北南港展覽館1館 4樓401會議室(台北市 11568 南港區經貿二路 1 號)
歡迎對醫療科技與創業投資有興趣的產業相關夥伴一起來共襄盛舉!

Registration Link:https://www.accupass.com/go/TMUxBExSCHS-DemoDay

Agenda

Time Activities
11:30-12:00

Registration|報到

12:00-12:30

Opening & Guest Remarks|開場 & 貴賓致詞

12:30-12:35

Intro|加速器介紹

12:35-14:15

Pitch Session|新創發表

14:15-14:30

Break|中場休息/投票

14:30-14:50

Panel Discussion 1|座談會1
Global Innovation Policy in Shaping the Future of Healthcare.

14:50-15:20

Panel Discussion 2|座談會2
Best Practices in Building a Strong National Innovation Ecosystem

15:20-15:30

開票&頒獎

15:30-16:30

閉幕&交流時間

【BE粉專】:https://www.facebook.com/beaccelerator

【北醫生醫加速器粉專】:https://www.facebook.com/tmubiomedaccelerator/

【IRCAD-Taiwan秀傳亞洲遠距微創手術中心粉專】:https://www.facebook.com/ircadtaiwan

7/29

TCI Event

生技大聯盟-個人化精準檢測與醫療未來趨勢
日期: 7/29 (六)
時間: 10:00-14:30
地點: 404會議室
主辦方: 大江基因股份有限公司

 
時間 內容 講者
10:10-11:00

萬病之源始於腸,保腸護命新解方

高雄市立小港醫院院長 郭昭宏醫師
11:10-12:00

感染病原基因定序應用與發展

台大醫院感染科 盛望徽醫師
12:00-13:30

Break

 
13:30-14:30

心血管用藥指引應用與發展

台北榮總心臟內科 胡瑜峰醫師
 
生技大聯盟-產學聯盟資金支持計畫
日期: 7/29 (六)
時間: 15:00-17:00
地點: 403會議室
主辦方: 大江生醫股份有限公司

 
時間 內容 講者
15:15-15:25

產學及臨床成功案例分享

國立台灣大學 楊泮池校長
15:25-15:45

柑橘幼果論文成果發表

中山醫學大學 徐慶琳教授
15:45-17:00

無限創研 論文計畫

大江生醫 博士團隊
 
生技大聯盟-供應商大會
日期: 7/29 (六)
時間: 15:00-17:00
地點: 404會議室
主辦方: 大江生醫股份有限公司

 
時間 內容 講者
15:00-15:20

大江生醫董事長致詞

大江生醫董事長 林詠翔
15:20-16:00

AI未來科技結合原料採購應用分享

 
16:10-17:00

全球採購策略佈局發布

大江生醫採購主管 李秋月

7/29

Trends in Next Generation Sequencing: Quality Management and Industrial Development

With the introduction of information technology, artificial intelligence, 5G, and extensive data analysis in the biomedical industry, Next Generation Sequencing (NGS) technology has become increasingly important. However, the issues of how to build a laboratory quality managment system of genetic testing in Taiwan to connect with global standards, utilize the benefits of big data, promote the clinical benefits of precision medicine, and pave the way for National Health Insurance coverage of NGS need further discussions by key stakeholders..
Using NGS technology to promote precision health has been a shared goal for many nations in recent years, and Taiwan must not fall behind. Taiwan Society of Pathology and PwC Legal Taiwan co-host this symposium to bring together participants from the industry, government, research institutes, and medical field. Join us for this unique opportunity for the advancement of precision medicine in Taiwan.

  • Organizer: Taiwan Society of Pathology
  • Co-organizer: Taiwan Oncology Society, Taiwan Society of Laboratory Medicine, Precision Medicine Industry Association of Taiwan
  • Administrator: PwC Legal Taiwan
  • Date and Time: July 29, 2023 (Sat.) 09:00 - 12:05 (Registration start at 08:40)
  • Venue: Taipei Nangang Exhibition Center Hall 1, 5F, Room 505 (5F., No. 1, Jingmao 2nd Rd., Nangang Dist., Taipei City 11568)
Agenda

時間

議程

講者

08:40 – 09:00

Registration

09:00 – 09:20

Opening Remarks

Chung-Liang Shih, Director General, National Health Insurance Administration
Yung-Ming Jeng, Chairman, Taiwan Society of Pathology
Muh-Hwa Yang, Director, Taiwan Oncology Society
Ming-Shih Lee, Chairman, Taiwan Society of Laboratory Medicine
Johnsee Lee, Chairman, Bio Asia-Taiwan
Zoe Chou, Health Industry Leader, PwC Taiwan

09:20 – 10:00

Topic 1
Outlook of National Health Insurance Coverage for NGS Diagnostics

Moderator
Audrey Tseng, Honorary Deputy Chairman, PwC Taiwan
Speakers
Chung-Liang Shih, Director General, National Health Insurance Administration
James Chih-Hsin Yang, Superintendent, National Taiwan University Cancer Center 

10:00 – 10:40

Topic 2
Trends in Laboratory Quality Management of NGS Diagnostics

Moderator
Yung-Ming Jeng, Chairman, Taiwan Society of Pathology
Speakers
Chiung-Ru Lai, Vice Chairperson of Ministry of Health and Welfare LDT Consultation Board and Leader of LDT Review Project
Ming-Shih Lee, Chairman, Taiwan Society of Laboratory Medicine
Chris Tsai, Chairman, Precision Medicine Industry Association of Taiwan

10:40 – 11:00

Break

11:00 – 11:30

Topic 3
Promotion of NGS Genomic Database

Moderator
Kuan-Yu Lin, Section Manager, Institute for Information Industry - Science & Technology Law Institute
Speakers
Shiu-Feng Huang, Director, National Biobank Consortium of Taiwan
Li-Ying Huang, Director, Center for Drug Evaluation

11:30 – 12:00

Closing Remarks

Moderator
Yung-Ming Jeng, Chairman, Taiwan Society of Pathology
Speakers
National Health Insurance Administration Medical Affairs Division
Muh-Hwa Yang, Director, Taiwan Oncology Society
Ming-Shih Lee, Chairman, Taiwan Society of Laboratory Medicine

12:00 – 12:30

 

Tour of BIO Asia-Taiwan Exhibition Floor

12:30 – 14:00

Group Lunch

7/29

BIO-ASIA Regulatory Forum

  COVID疫情催化下,伴隨著科技進化的推波助瀾,改變了醫療服務及醫藥產業的營運模式。在後疫情時代,法規監管機構做為民眾使用藥品的守門員,為確保民眾即時使用到安全、有效、具品質保證之醫藥品,法規規範與管理也進行了大幅度的調整。您想了解美國FDA與歐盟EMA,因應疫情,推行的新法規政策,以及面對這些新的法規規範,生技醫藥產業可能的因應策略與未來趨勢?同時,為回應疫情,數位醫療科技的相助帶來了臨床試驗的轉型,分散式臨床試驗(Decentralized Clinical Trial, DCT)將對未來的醫藥產業、醫療機構及民眾帶來什麼樣的變化?
    台灣醫藥品法規學會非常榮幸邀請到長期深耘國際醫藥產業的王慧君執行長、Linus Kao副總裁,以及食品藥物管理署長官,分享對醫藥品監管法規趨勢的見解,及美、歐、台灣監管機構對DCT的政策措施等。竭誠歡迎對醫藥品法規及臨床試驗議題關切之會員及各界先進踴躍報名參加!
 

主辦單位:台灣醫藥品法規學會
會議時間:2023年7月29日(星期六)下午1點30分
會議地點:亞洲生技大會現場 504A會議室(南港展覽館一館5樓)
報名連結:https://forms.gle/d6FGS6pg2AK5rSox5

Agenda

時間

Time

主題

Topic

講者

Speaker

主持人

Moderator

13:00 – 13:30

報到

13:30 – 13:40

開幕

康照洲 理事長
台灣醫藥品法規學會

13:40 – 14:30

State of the Art in Drug
Development and Health

Authority Engagement

王慧君 執行長
台灣浩鼎生技股份有限公司

黃文英 董事長暨總經理
安基生技新藥(股)公司

14:30 – 15:00

US/EU DCT Rregulation

and Development

Linus Kao Vice President
Europe-Taiwan Biotech Association

康照洲 理事長
台灣醫藥品法規學會

15:00 – 15:20

茶敘Tea and Coffee Break

 

15:20 – 15:50

台灣藥品臨床試驗執行

散式措施指引

張婷雅 科長
衛生福利部食品藥物管理署

高純琇 主任
臺大藥學專業學院國際藥政法規科學研究平台

15:50 – 16:50

綜合討論

與談人:
黃文英 董事長暨總經理

王慧君 執行長
Linus Kao Vice President
高純琇 主任
張婷雅 科長
陳恒德 常務理事

康照洲 理事長
台灣醫藥品法規學會

16:50 – 17:00

閉幕

康照洲 理事長
台灣醫藥品法規學會

 

聯絡人:鍾明翰、譚筱曉,TEL:(02)2747-3625,E-MAIL:tsrap@tsrap.org.tw,更多訊息請參考學會官網 (http://tsrap.org.tw/)